Literature DB >> 29966783

Drivers of Cost in Adult Thoracolumbar Spine Deformity Surgery.

Byron F Stephens1, Inamullah Khan1, Silky Chotai2, Ahilan Sivaganesan3, Clinton J Devin4.   

Abstract

BACKGROUND: In an era of rising health care costs, it is prudent to consider effective use of resources. Given the rapidly expanding elderly population with an anticipated increase in adult spinal deformity, identifying the significant cost drivers for the surgical management is an important step in the process of increasing sustainability and cost-effectiveness of adult spinal deformity surgery.
METHODS: A total of 129 patients undergoing elective spine surgery for thoraco-lumbar deformity were enrolled in a prospective longitudinal registry. Patient-reported resource use during the 3-month postoperative period, including outpatient visits, spine-related diagnostic tests, injections, emergency department room visits, rehabilitation/skilled nursing facility utilization, and use of all medications, was collected in a single-center prospective registry. Multiple linear regression analysis was conducted to find the significant patient coefficient for the cost variability.
RESULTS: The study population showed significant improvement (P < 0.001) in all patient-reported outcomes including disability (Oswestry Disability Index), pain (Numeric Rating Scale for Back Pain and Numeric Rating Scale for Leg Pain), and quality of life (Euro-Qol-5D). In risk-adjusted multiple patient comorbidities including chronic obstructive pulmonary disease and diabetes, preoperative deformity diagnosis, number of levels involved, length of surgery and hospital stay, 90-day readmission and use of inpatient rehabilitation were the significant drivers of the cost.
CONCLUSIONS: Our study demonstrates that several patient-specific, surgery-related factors, 90-day readmission and postdischarge inpatient rehabilitation use, were associated with increased cost associated with the adult deformity spine surgery. Published by Elsevier Inc.

Entities:  

Keywords:  Adult spine; Cost; Cost effectiveness; Deformity; Spine

Mesh:

Year:  2018        PMID: 29966783     DOI: 10.1016/j.wneu.2018.06.155

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  COVID-19 Significantly Impacted Hospital Length of Stay and Discharge Patterns for Adult Spinal Deformity Patients.

Authors:  Kevin Y Wang; Emmanuel L McNeely; Suraj A Dhanjani; Micheal Raad; Varun Puvanesarajah; Brian J Neuman; David Cohen; Akhil J Khanna; Floreana Kebaish; Hamid Hassanzadeh; Khaled M Kebaish
Journal:  Spine (Phila Pa 1976)       Date:  2021-11-15       Impact factor: 3.241

2.  Bundled Payment Models in Spine Surgery.

Authors:  Kevin Hines; Nikolaos Mouchtouris; Charles Getz; Glenn Gonzalez; Thiago Montenegro; Adam Leibold; James Harrop
Journal:  Global Spine J       Date:  2021-04

3.  Spine Instrumented Surgery on a Budget-Tools for Lowering Cost Without Changing Outcome.

Authors:  Ilyas Eli; Robert G Whitmore; Zoher Ghogawala
Journal:  Global Spine J       Date:  2021-04

4.  Cost-Effectiveness of Adult Spinal Deformity Surgery.

Authors:  Anthony M Alvarado; Bryan A Schatmeyer; Paul M Arnold
Journal:  Global Spine J       Date:  2020-10-14

5.  Factors Associated With Short Length of Stay After Long Fusions for Adult Spinal Deformity: Initial Steps Toward Developing an Enhanced Recovery Pathway.

Authors:  Francis Lovecchio; Michael Steinhaus; Jonathan Charles Elysee; Alex Huang; Bryan Ang; Renaud Lafage; Jingyan Yang; Ellen Soffin; Chad Craig; Virginie Lafage; Frank Schwab; Han Jo Kim
Journal:  Global Spine J       Date:  2020-08-13

6.  Postoperative Complication Burden, Revision Risk, and Health Care Use in Obese Patients Undergoing Primary Adult Thoracolumbar Deformity Surgery.

Authors:  Kunal Varshneya; Dhiraj J Pangal; Martin N Stienen; Allen L Ho; Parastou Fatemi; Zachary A Medress; Daniel B Herrick; Atman Desai; John K Ratliff; Anand Veeravagu
Journal:  Global Spine J       Date:  2020-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.